MRNA Moderna
Permanent stock page ↗Health Care · S&P 500 · Nasdaq 100
Next earnings: not announced yet
What 30 analyst firms say about Moderna: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
28 rated views · 32 analyst/firm records · 30 firms
Radar score
- S&P 500 · Top Picks · 6MNot scored · Average target is not above the current price
- S&P 500 · Safest consensus · 6MNot scored · Average target is not above the current price
Other indices (1)
- Nasdaq 100 · Top Picks · 6MNot scored · Average target is not above the current price
- Nasdaq 100 · Safest consensus · 6MNot scored · Average target is not above the current price
Recent analyst activity · last 90 days
Our tracked history has 38 reports on MRNA from 26 analyst firms in the last 90 days (30 firms in the past year).
Comparing each firm's latest target with its previous one: 6 raised their price target, 5 left it unchanged and 7 have their first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: Piper Sandler raised its target from $167.00 (set 20 Aug 2026) to $230.00 on 25 Oct 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Argus | Jasper Hellweg | Buy | 28 Aug 2026 | 180.00 USD |
| Argus | John Eade | Buy | 28 Aug 2026 | 180.00 USD |
| Bank of America Securities | Dimple Gosai | Hold | 9 Oct 2026 | 200.00 USD |
| Barclays | Eliana Merle | Hold | 24 Aug 2026 | 125.00 USD |
| Berenberg | Harry Gillis | Hold | 3 Aug 2026 | 100.00 USD |
| Bernstein | Courtney Breen | Hold | 19 Aug 2026 | 45.00 USD |
| BMO Capital Markets | Unnamed analyst | Buy | 12 Jan 2026 | — |
| Bradesco Corretora | Unnamed analyst | Buy | 28 Aug 2026 | — |
| Brookline Capital Markets | Leah R Cann | Buy | 31 Jul 2026 | Conflicting reports · excluded |
| Citigroup | Geoff Meacham | Sell | 23 Oct 2026 | 80.00 USD · 30 Sep 2026 |
| CLSA | Unnamed analyst | Buy | 28 Aug 2026 | — |
| DBS | Nico Chen | Hold | 11 Sep 2026 | 150.00 USD |
| Deutsche Bank | Unnamed analyst | Hold | 28 Aug 2026 | 125.00 USD |
| Evercore ISI | Cory Kasimov | Hold | 3 Sep 2026 | 80.00 USD |
| Goldman Sachs | Salveen Richter | Hold | 15 Oct 2026 | 137.00 USD |
| Jefferies | Andrew Tsai | Hold | 19 Aug 2026 | Conflicting reports · excluded |
| JPMorgan | Jessica Fye | Sell | 21 Aug 2026 | 77.00 USD |
| Leerink Partners | Mani Foroohar | Sell | 30 Jan 2026 | 17.00 USD |
| Loop Capital | Leah Rush Cann | — | 19 Aug 2026 | 135.00 USD |
| Morgan Stanley | Terence Flynn | Hold | 7 Oct 2026 | 95.00 USD |
| Needham | Joseph R Stringer | Hold | 1 Jun 2026 | — |
| Piper Sandler | Edward Tenthoff | Buy | 26 Oct 2026 | 230.00 USD |
| RBC Capital Markets | Luca Issi | Hold | 19 Aug 2026 | 130.00 USD |
| Redburn | Simon Baker | Sell | 3 Sep 2026 | 81.00 USD |
| Singular Research | Unnamed analyst | Hold | 23 Sep 2026 | — |
| TD Cowen | Tyler Van Buren | ConflictConflicting reports · excluded | 21 Oct 2026 | 90.00 USD |
| UBS | David Dai | Hold | 3 Sep 2026 | 150.00 USD |
| UBS | Michael Yee | Hold | 22 Sep 2026 | — |
| Weiss Ratings | Unnamed analyst | — | 9 Sep 2026 | — |
| William Blair | Myles Minter | ConflictConflicting reports · excluded | 27 Oct 2026 | — |
| Wolfe Research | Alexandria Hammond | Hold | 25 Aug 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 15 Jun 2026 | 236.00 USD |
Partial coverage · checked 6 Nov (6 Nov 2026, 03:59 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.